Selected research
Industry Growth & Trends
Global Formulation Development Services Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Formulation Development Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Formulation Development Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Formulation Development Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Formulation Development Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Formulation Development Services market include Coriolis Pharma, Aurigene Pharmaceutical Services, Adragos Pharma, Ascendia Pharmaceuticals, Dalton Pharma Services, Intertek, Suven Pharma, Agno Pharma and SGS SA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Formulation Development Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Formulation Development Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Formulation Development Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Formulation Development Services.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Formulation Development Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Formulation Development Services Market by Company
Coriolis Pharma
Aurigene Pharmaceutical Services
Adragos Pharma
Ascendia Pharmaceuticals
Dalton Pharma Services
Intertek
Suven Pharma
Agno Pharma
SGS SA
DPT Laboratories Ltd
MedPharm
Octavius Pharma
Pharmaron
CuriRx, Inc.
LGM pharma
Avivia BV
Corealis
Losan Pharma
Evonik Health Care
Lonza
Alcami
Scantox
Formulation Development Services Segment by Type
Food and Beverage Formula Development
Drug Formula Development
Cosmetic Formula Development
Health Care Product Formula Development
Others
Formulation Development Services Segment by Application
Large Enterprises
Small and Medium Enterprises
Formulation Development Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Formulation Development Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Formulation Development Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Formulation Development Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Formulation Development Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Food and Beverage Formula Development
- Drug Formula Development
- Cosmetic Formula Development
- Health Care Product Formula Development
- Others
Applications
- Large Enterprises
- Small and Medium Enterprises
Companies covered
- Coriolis Pharma
- Aurigene Pharmaceutical Services
- Adragos Pharma
- Ascendia Pharmaceuticals
- Dalton Pharma Services
- Intertek
- Suven Pharma
- Agno Pharma
- SGS SA
- DPT Laboratories Ltd
- MedPharm
- Octavius Pharma
- Pharmaron
- CuriRx, Inc.
- LGM pharma
- Avivia BV
- Corealis
- Losan Pharma
- Evonik Health Care
- Lonza
- Alcami
- Scantox
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Formulation Development Services Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Formulation Development Services Market Size by Region (2021-2032)
- 1.4.1 Global Formulation Development Services Market Size by Region (2021-2026)
- 1.4.2 Global Formulation Development Services Market Size by Region (2027-2032)
- 1.5 Key Regions Formulation Development Services Market Size (2021-2032)
- 1.5.1 North America Formulation Development Services Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Formulation Development Services Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Formulation Development Services Market Size Growth Rate (2021-2032)
- 1.5.4 South America Formulation Development Services Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Formulation Development Services Market Size Growth Rate (2021-2032)
2 Formulation Development Services Market by Type
- 2.1 Type Introduction
- 2.1.1 Food and Beverage Formula Development
- 2.1.2 Drug Formula Development
- 2.1.3 Cosmetic Formula Development
- 2.1.4 Health Care Product Formula Development
- 2.1.5 Others
- 2.2 Global Formulation Development Services Market Size by Type
- 2.2.1 Global Formulation Development Services Market Size Overview by Type (2021-2032)
- 2.2.2 Global Formulation Development Services Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Formulation Development Services Market Size Forecasted by Type (2027-2032)
- 2.3 Global Formulation Development Services Market Size by Regions
- 2.3.1 North America Formulation Development Services Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Formulation Development Services Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Formulation Development Services Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Formulation Development Services Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Formulation Development Services Market Size Breakdown by Type (2021-2026)
3 Formulation Development Services Market by Application
- 3.1 Type Introduction
- 3.1.1 Large Enterprises
- 3.1.2 Small and Medium Enterprises
- 3.2 Global Formulation Development Services Market Size by Application
- 3.2.1 Global Formulation Development Services Market Size Overview by Application (2021-2032)
- 3.2.2 Global Formulation Development Services Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Formulation Development Services Market Size Forecasted by Application (2027-2032)
- 3.3 Global Formulation Development Services Market Size by Regions
- 3.3.1 North America Formulation Development Services Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Formulation Development Services Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Formulation Development Services Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Formulation Development Services Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Formulation Development Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Formulation Development Services Industry Trends
- 4.2 Formulation Development Services Industry Drivers
- 4.3 Formulation Development Services Industry Opportunities and Challenges
- 4.4 Formulation Development Services Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Formulation Development Services Revenue (2021-2026)
- 5.2 Global Formulation Development Services Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Formulation Development Services Key Company Headquarters & Area Served
- 5.4 Global Formulation Development Services Company, Product Type & Application
- 5.5 Global Formulation Development Services Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Formulation Development Services Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Formulation Development Services Players Market Share by Revenue in 2025
- 5.6.3 2025 Formulation Development Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Coriolis Pharma
- 6.1.1 Coriolis Pharma Company Information
- 6.1.2 Coriolis Pharma Business Overview
- 6.1.3 Coriolis Pharma Formulation Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Coriolis Pharma Formulation Development Services Product Portfolio
- 6.1.5 Coriolis Pharma Recent Developments
- 6.2 Aurigene Pharmaceutical Services
- 6.2.1 Aurigene Pharmaceutical Services Company Information
- 6.2.2 Aurigene Pharmaceutical Services Business Overview
- 6.2.3 Aurigene Pharmaceutical Services Formulation Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Aurigene Pharmaceutical Services Formulation Development Services Product Portfolio
- 6.2.5 Aurigene Pharmaceutical Services Recent Developments
- 6.3 Adragos Pharma
- 6.3.1 Adragos Pharma Company Information
- 6.3.2 Adragos Pharma Business Overview
- 6.3.3 Adragos Pharma Formulation Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Adragos Pharma Formulation Development Services Product Portfolio
- 6.3.5 Adragos Pharma Recent Developments
- 6.4 Ascendia Pharmaceuticals
- 6.4.1 Ascendia Pharmaceuticals Company Information
- 6.4.2 Ascendia Pharmaceuticals Business Overview
- 6.4.3 Ascendia Pharmaceuticals Formulation Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Ascendia Pharmaceuticals Formulation Development Services Product Portfolio
- 6.4.5 Ascendia Pharmaceuticals Recent Developments
- 6.5 Dalton Pharma Services
- 6.5.1 Dalton Pharma Services Company Information
- 6.5.2 Dalton Pharma Services Business Overview
- 6.5.3 Dalton Pharma Services Formulation Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Dalton Pharma Services Formulation Development Services Product Portfolio
- 6.5.5 Dalton Pharma Services Recent Developments
- 6.6 Intertek
- 6.6.1 Intertek Company Information
- 6.6.2 Intertek Business Overview
- 6.6.3 Intertek Formulation Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Intertek Formulation Development Services Product Portfolio
- 6.6.5 Intertek Recent Developments
- 6.7 Suven Pharma
- 6.7.1 Suven Pharma Company Information
- 6.7.2 Suven Pharma Business Overview
- 6.7.3 Suven Pharma Formulation Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Suven Pharma Formulation Development Services Product Portfolio
- 6.7.5 Suven Pharma Recent Developments
- 6.8 Agno Pharma
- 6.8.1 Agno Pharma Company Information
- 6.8.2 Agno Pharma Business Overview
- 6.8.3 Agno Pharma Formulation Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Agno Pharma Formulation Development Services Product Portfolio
- 6.8.5 Agno Pharma Recent Developments
- 6.9 SGS SA
- 6.9.1 SGS SA Company Information
- 6.9.2 SGS SA Business Overview
- 6.9.3 SGS SA Formulation Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 SGS SA Formulation Development Services Product Portfolio
- 6.9.5 SGS SA Recent Developments
- 6.10 DPT Laboratories Ltd
- 6.10.1 DPT Laboratories Ltd Company Information
- 6.10.2 DPT Laboratories Ltd Business Overview
- 6.10.3 DPT Laboratories Ltd Formulation Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 DPT Laboratories Ltd Formulation Development Services Product Portfolio
- 6.10.5 DPT Laboratories Ltd Recent Developments
- 6.11 MedPharm
- 6.11.1 MedPharm Company Information
- 6.11.2 MedPharm Business Overview
- 6.11.3 MedPharm Formulation Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 MedPharm Formulation Development Services Product Portfolio
- 6.11.5 MedPharm Recent Developments
- 6.12 Octavius Pharma
- 6.12.1 Octavius Pharma Company Information
- 6.12.2 Octavius Pharma Business Overview
- 6.12.3 Octavius Pharma Formulation Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Octavius Pharma Formulation Development Services Product Portfolio
- 6.12.5 Octavius Pharma Recent Developments
- 6.13 Pharmaron
- 6.13.1 Pharmaron Company Information
- 6.13.2 Pharmaron Business Overview
- 6.13.3 Pharmaron Formulation Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Pharmaron Formulation Development Services Product Portfolio
- 6.13.5 Pharmaron Recent Developments
- 6.14 CuriRx, Inc.
- 6.14.1 CuriRx, Inc. Company Information
- 6.14.2 CuriRx, Inc. Business Overview
- 6.14.3 CuriRx, Inc. Formulation Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 CuriRx, Inc. Formulation Development Services Product Portfolio
- 6.14.5 CuriRx, Inc. Recent Developments
- 6.15 LGM pharma
- 6.15.1 LGM pharma Company Information
- 6.15.2 LGM pharma Business Overview
- 6.15.3 LGM pharma Formulation Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 LGM pharma Formulation Development Services Product Portfolio
- 6.15.5 LGM pharma Recent Developments
- 6.16 Avivia BV
- 6.16.1 Avivia BV Company Information
- 6.16.2 Avivia BV Business Overview
- 6.16.3 Avivia BV Formulation Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Avivia BV Formulation Development Services Product Portfolio
- 6.16.5 Avivia BV Recent Developments
- 6.17 Corealis
- 6.17.1 Corealis Company Information
- 6.17.2 Corealis Business Overview
- 6.17.3 Corealis Formulation Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Corealis Formulation Development Services Product Portfolio
- 6.17.5 Corealis Recent Developments
- 6.18 Losan Pharma
- 6.18.1 Losan Pharma Company Information
- 6.18.2 Losan Pharma Business Overview
- 6.18.3 Losan Pharma Formulation Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Losan Pharma Formulation Development Services Product Portfolio
- 6.18.5 Losan Pharma Recent Developments
- 6.19 Evonik Health Care
- 6.19.1 Evonik Health Care Company Information
- 6.19.2 Evonik Health Care Business Overview
- 6.19.3 Evonik Health Care Formulation Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Evonik Health Care Formulation Development Services Product Portfolio
- 6.19.5 Evonik Health Care Recent Developments
- 6.20 Lonza
- 6.20.1 Lonza Company Information
- 6.20.2 Lonza Business Overview
- 6.20.3 Lonza Formulation Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Lonza Formulation Development Services Product Portfolio
- 6.20.5 Lonza Recent Developments
- 6.21 Alcami
- 6.21.1 Alcami Company Information
- 6.21.2 Alcami Business Overview
- 6.21.3 Alcami Formulation Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.21.4 Alcami Formulation Development Services Product Portfolio
- 6.21.5 Alcami Recent Developments
- 6.22 Scantox
- 6.22.1 Scantox Company Information
- 6.22.2 Scantox Business Overview
- 6.22.3 Scantox Formulation Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.22.4 Scantox Formulation Development Services Product Portfolio
- 6.22.5 Scantox Recent Developments
7 North America
- 7.1 North America Formulation Development Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Formulation Development Services Market Size by Country (2021-2026)
- 7.3 North America Formulation Development Services Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Formulation Development Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Formulation Development Services Market Size by Country (2021-2026)
- 8.3 Europe Formulation Development Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Formulation Development Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Formulation Development Services Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Formulation Development Services Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Formulation Development Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Formulation Development Services Market Size by Country (2021-2026)
- 10.3 South America Formulation Development Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Formulation Development Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Formulation Development Services Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Formulation Development Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst